280 related articles for article (PubMed ID: 26121266)
1. Emergence of Ciprofloxacin-Resistant Salmonella enterica Serovar Typhi in Italy.
García-Fernández A; Gallina S; Owczarek S; Dionisi AM; Benedetti I; Decastelli L; Luzzi I
PLoS One; 2015; 10(6):e0132065. PubMed ID: 26121266
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
[TBL] [Abstract][Full Text] [Related]
3. Hotspots sequences of gyrA, gyrB, parC, and parE genes encoded for fluoroquinolones resistance from local Salmonella Typhi strains in Jakarta.
Nathania I; Nainggolan IM; Yasmon A; Nusatia ACM; Tjoa E; Gunardi WD; Moehario LH
BMC Microbiol; 2022 Oct; 22(1):250. PubMed ID: 36253712
[TBL] [Abstract][Full Text] [Related]
4. Novel restriction enzyme SSiI for the detection of mutation in GyrA gene of Salmonella enterica serovar Typhi.
Agrawal P; Kapila K; Kumar S; Ghosh AN; Maurya AK
Indian J Pathol Microbiol; 2010; 53(3):509-12. PubMed ID: 20699513
[TBL] [Abstract][Full Text] [Related]
5. Detection of mutations in the gyrA gene in fluoroquinolone resistance Salmonella enterica serotypes typhi and paratyphi A isolated from the Infectious Diseases Hospital, Kuwait.
Dimitrov T; Dashti AA; Albaksami O; Jadaon MM
J Clin Pathol; 2010 Jan; 63(1):83-7. PubMed ID: 19889623
[TBL] [Abstract][Full Text] [Related]
6. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
Turner AK; Nair S; Wain J
J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
[TBL] [Abstract][Full Text] [Related]
7. Ciprofloxacin-resistant Salmonella enterica serovar typhi from Kuwait with novel mutations in gyrA and parC genes.
Dimitrov T; Dashti AA; Albaksami O; Udo EE; Jadaon MM; Albert MJ
J Clin Microbiol; 2009 Jan; 47(1):208-11. PubMed ID: 18971360
[TBL] [Abstract][Full Text] [Related]
8. Validation of Pefloxacin for detection of fluoroquinolone (FQ) resistance among
Inayath SB; Broor S; Gupta R; Agarwal P; Majumder S; Anveshi AK; Gaind R
J Med Microbiol; 2021 Aug; 70(8):. PubMed ID: 34356003
[No Abstract] [Full Text] [Related]
9. Reduced susceptibility to ciprofloxacin and gyra gene mutation in North Indian strains of Salmonella enterica serotype Typhi and serotype Paratyphi A.
Renuka K; Kapil A; Kabra SK; Wig N; Das BK; Prasad VV; Chaudhry R; Seth P
Microb Drug Resist; 2004; 10(2):146-53. PubMed ID: 15256030
[TBL] [Abstract][Full Text] [Related]
10. Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and Paratyphi A isolated in Katmandu, Nepal, in 2003.
Shirakawa T; Acharya B; Kinoshita S; Kumagai S; Gotoh A; Kawabata M
Diagn Microbiol Infect Dis; 2006 Apr; 54(4):299-303. PubMed ID: 16466897
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC, and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica.
Eaves DJ; Randall L; Gray DT; Buckley A; Woodward MJ; White AP; Piddock LJ
Antimicrob Agents Chemother; 2004 Oct; 48(10):4012-5. PubMed ID: 15388468
[TBL] [Abstract][Full Text] [Related]
12. DNA sequence analysis of DNA gyrase and DNA topoisomerase IV quinolone resistance-determining regions of Salmonella enterica serovar Typhi and serovar Paratyphi A.
Hirose K; Hashimoto A; Tamura K; Kawamura Y; Ezaki T; Sagara H; Watanabe H
Antimicrob Agents Chemother; 2002 Oct; 46(10):3249-52. PubMed ID: 12234852
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of clinical Streptococcus pneumoniae isolates with reduced susceptibility to fluoroquinolones emerging in Italy.
Montanari MP; Tili E; Cochetti I; Mingoia M; Manzin A; Varaldo PE
Microb Drug Resist; 2004; 10(3):209-17. PubMed ID: 15383164
[TBL] [Abstract][Full Text] [Related]
14. Bacteraemia with pleural effusions complicating typhoid fever caused by high-level ciprofloxacin-resistant Salmonella enterica serotype Typhi.
Mohanty S; Gaind R; Paglietti B; Paul P; Rubino S; Deb M
Ann Trop Paediatr; 2010; 30(3):233-40. PubMed ID: 20828458
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial drug resistance of Salmonella enterica serovar typhi in asia and molecular mechanism of reduced susceptibility to the fluoroquinolones.
Chau TT; Campbell JI; Galindo CM; Van Minh Hoang N; Diep TS; Nga TT; Van Vinh Chau N; Tuan PQ; Page AL; Ochiai RL; Schultsz C; Wain J; Bhutta ZA; Parry CM; Bhattacharya SK; Dutta S; Agtini M; Dong B; Honghui Y; Anh DD; Canh DG; Naheed A; Albert MJ; Phetsouvanh R; Newton PN; Basnyat B; Arjyal A; La TT; Rang NN; Phuong LT; Van Be Bay P; von Seidlein L; Dougan G; Clemens JD; Vinh H; Hien TT; Chinh NT; Acosta CJ; Farrar J; Dolecek C
Antimicrob Agents Chemother; 2007 Dec; 51(12):4315-23. PubMed ID: 17908946
[TBL] [Abstract][Full Text] [Related]
16. Suitable disk antimicrobial susceptibility breakpoints defining Salmonella enterica serovar Typhi isolates with reduced susceptibility to fluoroquinolones.
Parry CM; Thuy CT; Dongol S; Karkey A; Vinh H; Chinh NT; Duy PT; Thieu Nga TV; Campbell JI; Van Minh Hoang N; Arjyal A; Bhutta ZA; Bhattacharya SK; Agtini MD; Dong B; Canh DG; Naheed A; Wain J; Tinh Hien T; Basnyat B; Ochiai L; Clemens J; Farrar JJ; Dolecek C; Baker S
Antimicrob Agents Chemother; 2010 Dec; 54(12):5201-8. PubMed ID: 20837759
[TBL] [Abstract][Full Text] [Related]
17. Emergence of fluoroquinolone-resistant strains of Salmonella enterica in Surabaya, Indonesia.
Yanagi D; de Vries GC; Rahardjo D; Alimsardjono L; Wasito EB; De I; Kinoshita S; Hayashi Y; Hotta H; Osawa R; Kawabata M; Shirakawa T
Diagn Microbiol Infect Dis; 2009 Aug; 64(4):422-6. PubMed ID: 19631095
[TBL] [Abstract][Full Text] [Related]
18. Drug resistance patterns in Salmonella enterica subspecies enterica serotype Typhi strains isolated over a period of two decades, with special reference to ciprofloxacin and ceftriaxone.
Nath G; Maurya P
Int J Antimicrob Agents; 2010 May; 35(5):482-5. PubMed ID: 20188522
[TBL] [Abstract][Full Text] [Related]
19. Re-emerging chloramphenicol sensitivity and emerging low level ciprofloxacin resistance among Salmonella enterica serotype typhi isolates in North India.
Gupta V; Kaur J; Kaistha N
Trop Doct; 2009 Jan; 39(1):28-30. PubMed ID: 19211419
[TBL] [Abstract][Full Text] [Related]
20. Development of a real-time PCR assay for detection of gyrA mutations associated with reduced susceptibility to ciprofloxacin in Salmonella enterica serovar typhi and paratyphi A.
Morita M; Ito K; Hirose K; Takahashi H; Shimuta K; Terajima J; Ohnishi M; Harada M; Matsuzaki M; Watanabe H; Izumiya H
Microbiol Immunol; 2006; 50(9):707-11. PubMed ID: 16985292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]